FDA Requirements for Providing Datasets for Nonclinical Studies in SEND Format Blog FDA Requirements for Providing Datasets for Nonclinical Studies in SEND Format 2025 年 3 月 19 日 The CDISC Standard for the Exchange of Nonclinical Data (SEND) provides the…Mahumood Hameed2025 年 3 月 19 日
Rolling NDA and BLA Submissions: Accelerate Your Review Timeline Blog 滚动提交 NDA 和 BLA:加快审核进度 We look at the growing regulatory trend of rolling NDA and BLA submissions to help…Evan Richardson2025 年 2 月 3 日
How To Respond to Health Authority Questions Blog How To Respond to Health Authority Questions Your biotech company has just submitted the marketing application for your first drug product. It’s…Danielle Pillsbury2024 年 10 月 25 日
Application of physiologically based pharmacokinetic modeling of novel drugs approved by the U.S. food and drug administration Publication 美国 FDA 批准的新型药物应用基于生理的药代动力学模型应用 The article from the European Journal of Pharmaceutical Sciences reviews the role of Physiologically Based…Danielle Pillsbury2024 年 9 月 1 日
Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates Blog 对 FDA 新抗体-药物偶联物临床药理指南的思考 In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies…Jim Gallagher2024 年 5 月 10 日
How to Navigate the FDA Landscape for an Orphan Drug Blog 如何在 FDA 的监管下开发孤儿药 罕见病是公共卫生领域的优先事项。FDA has launched several programs and a final…Jim Gallagher2024 年 2 月 21 日
Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions Press Release Certara 宣布美国食品药品监督管理局对 Certara 生物模拟软件用于审查监管申报材料的事项予以更新与扩充 FDA holds more than 400 SimcypTM and PhoenixTM software licenses across 12 divisions and offices…Jim Gallagher2021 年 12 月 21 日
Mind the Gap: Best Practices in Clinical Pharmacology Gap Analysis Blog 注意差距:临床药理学差距分析最佳实践 您是否对参加考试感到焦虑?Many people do because they want to show…Certara2017 年 5 月 25 日